Literature DB >> 12748801

[Diabetic retinopathy. Pathophysiology and therapy of hypoxia-induced inflammation].

A M Joussen1, S Fauser, T U Krohne, K-D Lemmen, G E Lang, B Kirchhof.   

Abstract

Diabetic retinopathy is the most common chronic microvascular complication associated with diabetes mellitus. The development of diabetic retinopathy is a consequence of metabolic dysregulation. Hyperglycemia is a critical factor which is involved in basement membrane thickening, loss of pericytes and endothelial cells, and retinal capillary nonperfusion. We review the molecular basis of diabetic retinopathy and maculopathy and elaborate the role of growth factors and cytokines in the development of diabetic vascular alterations, their specific influence on the cellular interaction between retinal endothelial cells and pericytes, and the role of intravascular blood components.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748801     DOI: 10.1007/s00347-003-0800-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  7 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

Review 2.  [Pharmacological treatment of diabetic retinopathy].

Authors:  G E Lang
Journal:  Ophthalmologe       Date:  2004-12       Impact factor: 1.059

3.  [Therapy of diabetic retinopathy with somatostatin analogues].

Authors:  G E Lang
Journal:  Ophthalmologe       Date:  2004-03       Impact factor: 1.059

4.  Elevated serum fetuin-A levels are associated with grades of retinopathy in type 2 diabetic patients.

Authors:  Ahu Yilmaz; Tolga Yilmaz; Murat Gunay
Journal:  Int Ophthalmol       Date:  2017-10-25       Impact factor: 2.031

5.  Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy.

Authors:  Kyungwon Lee; Yang Hu; Lexi Ding; Ying Chen; Yusuke Takahashi; Robert Mott; Jian-Xing Ma
Journal:  Diabetes       Date:  2012-08-13       Impact factor: 9.461

6.  Structural alterations of the erythrocyte membrane proteins in diabetic retinopathy.

Authors:  Ioannis K Petropoulos; Panagiotis I Margetis; Marianna H Antonelou; John X Koliopoulos; Sotirios P Gartaganis; Lukas H Margaritis; Issidora S Papassideri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.535

7.  Antihypertriglyceridemia and anti-inflammatory activities of monascus-fermented dioscorea in streptozotocin-induced diabetic rats.

Authors:  Yeu-Ching Shi; Jiunn-Wang Liao; Tzu-Ming Pan
Journal:  Exp Diabetes Res       Date:  2011-05-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.